Orthofix Medical Inc. (OFIX) 📈: анализ компании, ее дивидендная стратегия и оценка мультипликаторов, прогноз цены и инвестиционные идеи для Orthofix Medical Inc.

1. Summary

Advantages

Price (11.16 $) is less than fair price (15.38 $)

Disadvantages

Dividends (0%) are below the sector average (0.527%).
The stock's return over the last year (-36.23%) is lower than the sector average (0%).
Current debt level 20.11% has increased over 5 years from 4.61%.
The company's current efficiency (ROE=-22.87%) is lower than the sector average (ROE=14.17%)

Similar companies

2. Share price and performance

2.1. Share price

2.3. Market efficiency

	Orthofix Medical Inc.	Healthcare	Index
7 days	-0.5%	-30.1%	1.2%
90 days	-21%	3.4%	21.7%
1 year	-36.2%	0%	21.8%

OFIX vs Sector: Orthofix Medical Inc. has significantly underperformed the "Healthcare" sector by -36.23% over the past year.

OFIX vs Market: Orthofix Medical Inc. has significantly underperformed the market by -58% over the past year.

Stable price: OFIX is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: OFIX with weekly volatility of -0.6968% over the past year.

3. Summary of the report

3.1. General

P/E: 0

P/S: 0.8347

More data on OFIX

3.2. Revenue

EPS	-3.3
ROE	-22.87%
ROA	-13.86%
ROIC	-9.8%
Ebitda margin	-4.28%

More data on OFIX

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (11.16 $) is lower than the fair price (15.38 $).

Price significantly below the fair price: The current price (11.16 $) is 37.8% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (64.15).

P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (90.03).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.33) is lower than that of the sector as a whole (18.96).

P/BV vs Market: The company's P/BV (1.33) is lower than that of the market as a whole (9.39).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.8347) is lower than that of the sector as a whole (32.77).

P/S vs Market: The company's P/S indicator (0.8347) is lower than that of the market as a whole (10.12).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-22.34) is lower than that of the sector as a whole (274.79).

EV/Ebitda vs Market: The company's EV/Ebitda (-22.34) is lower than that of the market as a whole (50.91).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -859.98% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-859.98%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).

5.4. ROE

ROE vs Sector: The company's ROE (-22.87%) is lower than that of the sector as a whole (14.17%).

ROE vs Market: The company's ROE (-22.87%) is lower than that of the market as a whole (11.64%).

5.5. ROA

ROA vs Sector: The company's ROA (-13.86%) is lower than that of the sector as a whole (1.18%).

ROA vs Market: The company's ROA (-13.86%) is lower than that of the market as a whole (6.89%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-9.8%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-9.8%) is lower than that of the market as a whole (11.08%).

6. Finance

6.1. Assets and debt

Debt level: (20.11%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 4.61% to 20.11%.

Excess of debt: The debt is not covered by net income, percentage -142.57%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.527%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date	Insider	Type	Price	Volume	Quantity
07.05.2025	Engine Capital Management, LP 10% Owner	Purchase	12.31	1 231 000	100 000
16.04.2025	Cedron Jorge Andres CLO	Sale	13.31	50 791	3 816
16.01.2025	Andrews Julie CFO	Sale	17.89	83 278	4 655

9. Stocks forum Orthofix Medical Inc.

Go to the shares forum "Orthofix Medical Inc." ⇨

Чем запомнились две короткие недели и что ждем на следующей

Макро
Россия
РУБЛЬ
Российский рубль в течение двух коротких недель показывал стабильную динамику, тогда как в выходные волатильность традиционно возрастала.

Биржевой курс рубля к юаню, за исключением 2 мая и открытия 5 мая, оставался в интервале 11,1–11,25 руб./юань.
Официальный курс рубля к доллару, установленный ЦБ, был в интервале 81–82,5 руб....

More

All blogs ⇨

Investing Port

Orthofix Medical Inc.

Company Analysis Orthofix Medical Inc.